GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
| GOVX Stock | USD 2.11 0.11 4.95% |
Slightly above 62% of GeoVax Labs' investor base is looking to short. The analysis of overall sentiment of trading GeoVax Labs stock suggests that many investors are alarmed at this time. GeoVax Labs' investing sentiment can be driven by a variety of factors including economic data, GeoVax Labs' earnings reports, geopolitical events, and overall market trends.
GeoVax |
ATLANTA, Ga., Oct. 02, 2024 -- GeoVax Labs, Inc. , a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today announced that its Chairman CEO, David Dodd, will participate in a panel discussion on innovative therapies for solid tumors at the 3rd Annual ROTH Healthcare Opportunities Conference taking place on October 9, 2024 in New York, NY. Senior GeoVax management will also host one-on-one meetings with registered attende
Read at finance.yahoo.com
 |
GeoVax Labs Fundamental Analysis
We analyze GeoVax Labs' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GeoVax Labs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GeoVax Labs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
GeoVax Labs is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
GeoVax Labs Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with GeoVax Labs stock to make a market-neutral strategy. Peer analysis of GeoVax Labs could also be used in its relative valuation, which is a method of valuing GeoVax Labs by comparing valuation metrics with similar companies.
Peers
GeoVax Labs Related Equities
| SONN | Sonnet Biotherapeutics | 29.87 | ||||
| IBIO | Ibio | 5.14 | ||||
| CDIO | Cardio Diagnostics | 3.28 | ||||
| OCGN | Ocugen | 1.33 | ||||
| ZURA | Zura Bio | 1.13 | ||||
| JAGX | Jaguar Animal | 1.19 | ||||
| QNRX | Quoin Pharmaceuticals | 3.28 | ||||
| ATNF | 180 Life | 3.29 | ||||
| ZVSA | ZyVersa Therapeutics | 5.41 | ||||
| ATXI | Avenue Therapeutics | 6.49 | ||||
| PHIO | Phio Pharmaceuticals | 7.66 | ||||
| REVB | Revelation Biosciences | 14.63 |
Additional Tools for GeoVax Stock Analysis
When running GeoVax Labs' price analysis, check to measure GeoVax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeoVax Labs is operating at the current time. Most of GeoVax Labs' value examination focuses on studying past and present price action to predict the probability of GeoVax Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeoVax Labs' price. Additionally, you may evaluate how the addition of GeoVax Labs to your portfolios can decrease your overall portfolio volatility.